Staphylococcus aureus evasion of innate antimicrobial defense (Q37225675)

19 August 2017

1 reference

title

Staphylococcus aureus evasion of innate antimicrobial defense (English)

1 reference

19 August 2017

Staphylococcus aureus

1 reference

2

Andreas Peschel

1 reference

19 August 2017

Dirk Kraus

1

1 reference

19 August 2017

1 August 2008

1 reference

19 August 2017

15

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

19 August 2017

3

1 reference

19 August 2017

4

1 reference

19 August 2017

437-451

1 reference

Staphylococcus aureus infections

19 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between 2000 and 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The changing epidemiology of Staphylococcus aureus?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus nasal carriage and surgical-site infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Immune evasion by staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcal innate immune evasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Unifying the epidemiological and evolutionary dynamics of pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Biological and biomedical implications of the co-evolution of pathogens and their hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Cholesterol attenuates the interaction of the antimicrobial peptide gramicidin S with phospholipid bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The co-evolution of host cationic antimicrobial peptides and microbial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Mammalian defensins: structures and mechanism of antibiotic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Alternative mechanisms of action of cationic antimicrobial peptides on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Defensins: antimicrobial peptides of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Cathelicidins and Innate Defense Against Invasive Bacterial Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Immunomodulatory properties of defensins and cathelicidins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Innate antimicrobial peptide protects the skin from invasive bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Innate defenses of the intestinal epithelial barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Molecular events in the activation of human neutrophils for microbial killing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Lactoferrin structure and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Perspectives on interactions between lactoferrin and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

How pathogenic bacteria evade mammalian sabotage in the battle for iron

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The ecological role of bacteriocins in bacterial competition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Role of Staphylococcus aureus catalase in niche competition against Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Thematic review series: skin lipids. Antimicrobial lipids at the skin surface

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

CspA regulates pigment production in Staphylococcus aureus through a SigB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Gram-positive three-component antimicrobial peptide-sensing system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The antimicrobial peptide-sensing system aps of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Topology and transport of membrane lipids in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Bacterial Resistance to Antimicrobial Host Defenses - An Emerging Target for Novel Antiinfective Strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal--leukocyte interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Multiple methionine sulfoxide reductase genes in Staphylococcus aureus: expression of activity and roles in tolerance of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

PerR controls oxidative stress resistance and iron storage proteins and is required for virulence in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Structure and biological activities of beta toxin from Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Inhibition of complement activation by a secreted Staphylococcus aureus protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Staphylococcus aureus capsular polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

In vitro and in vivo activity of antimicrobial peptides synthesized based on the insect defensin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Protective effects of synthetic antibacterial oligopeptides based on the insect defensins on Methicillin-resistant Staphylococcus aureus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Therapeutic effect of modified oligopeptides from the beetle Allomyrina dichotoma on methicillin-resistant Staphylococcus aureus (MRSA) infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Antimicrobial peptide therapeutics for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Inhibition of the D-alanine:D-alanyl carrier protein ligase from Bacillus subtilis increases the bacterium's susceptibility to antibiotics that target the cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

How do bacteria resist human antimicrobial peptides?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.4.437

21 January 2018

Identifiers

DOI

10.2217/17460913.3.4.437

1 reference

19 August 2017

1 reference

PubMed ID

18651815